| Date | Time | Source | Headline | Symbol | Company |
| 02/14/2019 | 4:00PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/12/2019 | 9:47AM | Edgar (US Regulatory) | Schedule 13g | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/07/2018 | 4:35PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Issuer (sc To-i/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/10/2018 | 4:20PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:39PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/08/2018 | 4:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/07/2018 | 9:11AM | Edgar (US Regulatory) | Tender Offer Statement by Issuer (sc To-i) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/07/2018 | 8:30AM | PR Newswire (US) | ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/07/2018 | 8:28AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/07/2018 | 6:00AM | PR Newswire (US) | Amneal and Impax Complete Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/04/2018 | 5:05PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/02/2018 | 6:19PM | PR Newswire (US) | Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/30/2018 | 6:20AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/27/2018 | 6:50PM | PR Newswire (US) | Amneal And Impax Receive FTC Clearance For Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/27/2018 | 6:30PM | PR Newswire (US) | ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/13/2018 | 5:04PM | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/10/2018 | 1:59PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/06/2018 | 7:33AM | PR Newswire (US) | Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/05/2018 | 5:24PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |